Second Interim Analysis of a Phase 3 Study Evaluating Idelalisib and Rituximab for Relapsed Chronic Lymphocytic Leukemia
Title:
Second Interim Analysis of a Phase 3 Study Evaluating Idelalisib and Rituximab for Relapsed Chronic Lymphocytic Leukemia
Author:
Pagel, John M. Coutre, Steven E. Furman, Richard R. Sharman, Jeff P. Cheson, Bruce D. Hillmen, Peter Barrientos, Jacqueline C. Zelenetz, Andrew D. Kipps, Thomas J. Flinn, Ian W. Ghia, Paolo Eradat, Herbert A. Ervin, Thomas Lamanna, Nicole Coiffier, Bertrand Pettitt, Andrew Li, Xiaoming Jahn, Thomas M. O’Brien, Susan M. Hallek, Michael J.